S T A T E O F N E W Y O R K
________________________________________________________________________
1502
2009-2010 Regular Sessions
I N S E N A T E
February 2, 2009
___________
Introduced by Sens. DeFRANCISCO, GOLDEN, LARKIN, LAVALLE, MORAHAN, VOLK-
ER -- read twice and ordered printed, and when printed to be committed
to the Committee on Health
AN ACT to amend the public health law, in relation to the duties of the
ethics committee of the empire state stem cell board
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Paragraphs (a) and (e) of subdivision 2 of section 265-b of
the public health law, as added by section 1 of part H of chapter 58 of
the laws of 2007, are amended to read as follows:
(a) provide for an independent scientific peer review committee
composed of individuals with expertise in the field of biomedical
research who shall review grant applications based on the criteria
requirements and standards adopted by the funding committee AND THE
ETHICS COMMITTEE, and make recommendations to the funding committee for
the award of grants;
(e) review grant applications based on the criteria, requirements, and
standards adopted by the funding committee AND THE ETHICS COMMITTEE
utilizing a process that gives due consideration to the amount of
nonpublic funds contributed by the project sponsor, including cash,
in-kind personnel, equipment or materials, donations, the opportunity to
leverage funds, including federal, private and not-for-profit funds
reasonably anticipated to be received by the project sponsors; provided,
however, that nonpublic funds shall only be considered as a factor by
the funding committee when reviewing applications of equivalent merit as
determined by the independent scientific peer review committee;
S 2. Subdivision 2 of section 265-c of the public health law, as added
by section 1 of part H of chapter 58 of the laws of 2007, is amended to
read as follows:
2. The ethics committee shall [make recommendations to the funding
committee regarding]:
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04782-01-9
S. 1502 2
(a) [scientific, medical, and] ESTABLISH ethical standards FOR GRANT
APPLICATIONS REVIEWED BY THE FUNDING COMMITTEE;
(b) ESTABLISH ETHICAL standards for all medical, socioeconomic, and
financial aspects of clinical trials and therapy delivery to patients,
including, but not limited to standards for safe and ethical procedures
for: obtaining materials and cells for research; clinical efforts for
the appropriate treatment of human subjects in medical research; and
ensuring compliance with patient privacy laws;
(c) EXERCISE oversight of funded research to ensure compliance with
the standards described in paragraphs (a) and (b) of this subdivision;
[and]
(d) ADVISE THE FUNDING COMMITTEE REGARDING relevant ethical and regu-
latory issues; AND
(E) ESTABLISH STANDARDS BY WHICH GRANT APPLICANTS SHALL CERTIFY THAT:
(I) ALL RESEARCH TO BE FUNDED BY THE GRANT SHALL BE CONDUCTED IN
COMPLIANCE WITH THE ETHICAL STANDARDS FOR RESEARCH SET FORTH BY THE
ETHICS COMMITTEE; AND
(II) STANDARDS AND PROCEDURES HAVE BEEN ESTABLISHED BY THE GRANT
RECIPIENT TO REVIEW ALL RESEARCH CONDUCTED PURSUANT TO THE GRANT, TO
ENSURE THAT THE ETHICAL STANDARDS ESTABLISHED BY THE ETHICS COMMITTEE
ARE FOLLOWED.
S 3. This act shall take effect immediately.